Literature DB >> 20068489

Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis.

Michele Heisler1, Hwajung Choi, Allison B Rosen, Sandeep Vijan, Mohammed Kabeto, Kenneth M Langa, John D Piette.   

Abstract

CONTEXT: It is well-documented that the financial burden of out-of-pocket expenditures for prescription drugs often leads people with medication-sensitive chronic illnesses to restrict their use of these medications. Less is known about the extent to which such cost-related medication underuse is associated with increases in subsequent hospitalizations and deaths.
OBJECTIVE: We compared the risk of hospitalizations among 5401 and of death among 6135 middle-aged and elderly adults with one or more cardiovascular diseases (diabetes, coronary artery disease, heart failure, and history of stroke) according to whether participants did or did not report restricting prescription medications because of cost. DESIGN AND
SETTING: A retrospective biannual cohort study across 4 cross-sectional waves of the Health and Retirement Study, a nationally representative survey of adults older than age 50. Using multivariate logistic regression to adjust for baseline differences in sociodemographic and health characteristics, we assessed subsequent hospitalizations and deaths between 1998 and 2006 for respondents who reported that they had or had not taken less medicine than prescribed because of cost.
RESULTS: Respondents with cardiovascular disease who reported underusing medications due to cost were significantly more likely to be hospitalized in the next 2 years, even after adjusting for other patient characteristics (adjusted predicted probability of 47% compared with 38%, P < 0.001). The more survey waves respondents reported cost-related medication underuse during 1998 to 2004, the higher the probability of being hospitalized in 2006 (adjusted predicted probability of 54% among respondents reporting cost-related medication underuse in all 4 survey waves compared with 42% among respondents reporting no underuse, P < 0.001). There was no independent association of cost-related medication underuse with death.
CONCLUSIONS: In this nationally representative cohort, middle-aged and elderly adults with cardiovascular disease who reported cutting back on medication use because of cost were more likely to report being hospitalized over a subsequent 2-year period after they had reported medication underuse. The more extensively respondents reported cost-related underuse over time, the higher their adjusted predicted probability of subsequent hospitalization.

Entities:  

Mesh:

Year:  2010        PMID: 20068489      PMCID: PMC3034735          DOI: 10.1097/MLR.0b013e3181c12e53

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  42 in total

1.  Problems paying out-of-pocket medication costs among older adults with diabetes.

Authors:  John D Piette; Michele Heisler; Todd H Wagner
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

2.  Pharmacy benefit plans and prescription drug spending.

Authors:  Donald M Steinwachs
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

3.  Medication costs, adherence, and health outcomes among Medicare beneficiaries.

Authors:  Ramin Mojtabai; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2003 Jul-Aug       Impact factor: 6.301

4.  Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries.

Authors:  Niteesh K Choudhry; Amanda R Patrick; Elliott M Antman; Jerry Avorn; William H Shrank
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

5.  Loss of health insurance and the risk for a decline in self-reported health and physical functioning.

Authors:  David W Baker; Joseph J Sudano; Jeffrey M Albert; Elaine A Borawski; Avi Dor
Journal:  Med Care       Date:  2002-11       Impact factor: 2.983

6.  Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

Authors:  S B Soumerai; J Avorn; D Ross-Degnan; S Gortmaker
Journal:  N Engl J Med       Date:  1987-08-27       Impact factor: 91.245

7.  Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk.

Authors:  John D Piette; Michele Heisler; Todd H Wagner
Journal:  Am J Public Health       Date:  2004-10       Impact factor: 9.308

8.  Prescription noncompliance due to cost among adults with disabilities in the United States.

Authors:  Jae Kennedy; Christopher Erb
Journal:  Am J Public Health       Date:  2002-07       Impact factor: 9.308

9.  Cost-related medication underuse: do patients with chronic illnesses tell their doctors?

Authors:  John D Piette; Michele Heisler; Todd H Wagner
Journal:  Arch Intern Med       Date:  2004-09-13

10.  The health effects of restricting prescription medication use because of cost.

Authors:  Michele Heisler; Kenneth M Langa; Elizabeth L Eby; A Mark Fendrick; Mohammed U Kabeto; John D Piette
Journal:  Med Care       Date:  2004-07       Impact factor: 2.983

View more
  48 in total

1.  Racial/ethnic disparities in access to physician care and medications among US stroke survivors.

Authors:  D A Levine; M V Neidecker; C I Kiefe; S Karve; L S Williams; J J Allison
Journal:  Neurology       Date:  2010-11-17       Impact factor: 9.910

Review 2.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

3.  High Out-of-Pocket Medical Spending among the Poor and Elderly in Nine Developed Countries.

Authors:  Katherine Baird
Journal:  Health Serv Res       Date:  2016-01-22       Impact factor: 3.402

4.  Cost-control mechanisms in Canadian private drug plans.

Authors:  Jillian Kratzer; Kimberlyn McGrail; Erin Strumpf; Michael R Law
Journal:  Healthc Policy       Date:  2013-08

5.  Designing and Testing an End-of-Life Discussion Intervention for African American Patients With Heart Failure and Their Families.

Authors:  Ubolrat Piamjariyakul; Carol E Smith; Marilyn Werkowitch; Noreen Thompson; Maria Fox; Karin Porter Williamson; Lori Olson
Journal:  J Hosp Palliat Nurs       Date:  2016-12       Impact factor: 1.918

6.  Does medication adherence following a copayment increase differ by disease burden?

Authors:  Virginia Wang; Chuan-Fen Liu; Christopher L Bryson; Nancy D Sharp; Matthew L Maciejewski
Journal:  Health Serv Res       Date:  2011-06-20       Impact factor: 3.402

7.  Recent trends in cost-related medication nonadherence among stroke survivors in the United States.

Authors:  Deborah A Levine; Lewis B Morgenstern; Kenneth M Langa; John D Piette; Mary A M Rogers; Sudeep J Karve
Journal:  Ann Neurol       Date:  2013-02-22       Impact factor: 10.422

Review 8.  Material need support interventions for diabetes prevention and control: a systematic review.

Authors:  Lily S Barnard; Deborah J Wexler; Darren DeWalt; Seth A Berkowitz
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

9.  Should national pharmacare apply a value-based insurance design?

Authors:  Kai Yeung; Steven G Morgan
Journal:  CMAJ       Date:  2019-07-22       Impact factor: 8.262

10.  Solutions to Address Diabetes-Related Financial Burden and Cost-Related Nonadherence: Results From a Pilot Study.

Authors:  Minal R Patel; Kenneth Resnicow; Ian Lang; Kathleen Kraus; Michele Heisler
Journal:  Health Educ Behav       Date:  2017-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.